A nationwide registry-based cohort study of the MammaPrint genomic risk classifier in invasive breast cancer.

Floris H Groenendijk,Agnes Jager,Fatima Cardoso,Carolien H M van Deurzen

The Breast（2018）

引用 14|浏览17

暂无评分

摘要

•Genomic risk stratification was associated with several histological parameters.•MammaPrint classified 52.6% of clinical high risk tumors as genomic low risk.•Correlation with genomic risk was better for PREDICT compared to Adjuvant!•62.7% of the MammaPrints in The Netherlands were performed on clinical low risktumors.

查看译文

关键词

Breast cancer,Adjuvant chemotherapy,Risk assessment,Cohort study,Genomic test,MammaPrint

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要